Molecular subtypes in breast cancer evaluation and management: divide and conquer (Q37052739)

17 August 2017

1 reference

title

Molecular subtypes in breast cancer evaluation and management: divide and conquer (English)

1 reference

17 August 2017

1 reference

2

1 reference

17 August 2017

Jeffrey Peppercorn

1

1 reference

PubMed ID

18181038

17 August 2017

Lisa A Carey

series ordinal

3

1 reference

17 August 2017

1 February 2008

1 reference

17 August 2017

1 reference

17 August 2017

26

1 reference

17 August 2017

1

1 reference

17 August 2017

1-10

1 reference

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Design of studies using DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Risk factors for breast cancer according to estrogen and progesterone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Folate intake and risk of breast cancer characterized by hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Cell-type-specific responses to chemotherapeutics in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

The role of BRCA1 in the cellular response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Gene expression profiling of breast cell lines identifies potential new basal markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

The impact of expression profiling on prognostic and predictive testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Limits of predictive models using microarray data for breast cancer clinical treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701784238

10.1080/07357900701784238

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18181038